**Chinese Library Classification No.** R446; R364; R741

Introduction {#sec1-1}
============

In mammals, spinal cord injury (SCI) is a destructive neurological disorder that often results in the loss of sensory and motor functions (Yu et al., 2016; Dyck and Karimi-Abdolrezaee, 2018; Sharma et al., 2019). After SCI, the non-regenerative characteristics of the central nervous system lead to neuronal death in the spinal cord (Pinto and Gotz, 2007; Wei et al., 2019). In contrast to mammals, adult zebrafish can achieve neuronal proliferation, regeneration and functional restoration within 6--8 weeks after SCI via several regenerative processes that evade cell death (Becker et al., 1998; Briona et al., 2015). Zebrafish and human genomes are highly homologous; therefore, zebrafish is used as a regeneration model (Howe et al., 2013). However, not all axons regenerate after SCI in adult zebrafish (Vajn et al., 2013) and the mechanisms of recovery after SCI in zebrafish and the significant differences between zebrafish axons are not fully understood.

In the past decade, there have been many studies on SCI in zebrafish that have identified SCI regeneration mechanisms that are similar between zebrafish and mammals. For example, fibroblast growth factor (FGF) signaling in zebrafish can promote regeneration after SCI by means of multiple mechanisms (Goldshmit et al., 2012). Similarly, many studies have demonstrated that FGF1 and FGF2 can protect neurons and promote axonal regeneration and recovery of movement function in mammalian SCI models (Kuo et al., 2011; Zhang et al., 2013). Other similar mechanisms involve bcl-2, phospho-Akt and miR-133b (Seki et al., 2003; Yu et al., 2011; Ogai et al., 2012; Zhang et al., 2016; Theis et al., 2017). Study of zebrafish regeneration mechanisms after SCI leads to understanding the zebrafish regeneration process and provides new research targets for SCI regeneration in mammals.

In recent years, microarray technology has been extensively used to study various biological mechanisms and a growing number of studies have used microarray technology to study the pathophysiology of diseases (Vogelstein et al., 2013; Hao et al., 2018). The purpose of this study was to identify the key genes and pathways involved in zebrafish axonal regeneration after SCI using bioinformatic methods and to provide new ideas and therapeutic targets for the treatment of mammalian SCI.

Materials and Methods {#sec1-2}
=====================

Identification of differentially expressed genes (DEGs) {#sec2-1}
-------------------------------------------------------

The original GSE56842 datasets were downloaded from NCBI GEO (available online: <http://www.ncbi.nlm.nih.gov/geo/>). These datasets were submitted by Vajn et al. (2013) and are based on the GPL1319 Platform (Affymetrix Zebrafish Genome Array, Affymetrix Technologies, Santa Clara, CA, USA). The data were derived from a complete spinal cord transection with fluoro-ruby retrograde tracing performed at the 8^th^ vertebral level in adult zebrafish. The fluoro-ruby dye labeled all the neurons in the brain that projected their axons to the 8^th^ vertebra. Three weeks later, fluoro-emerald was injected 4 mm distal to the spinal cord transection site, thereby labeling all neurons that regenerated their axons to this level. The zebrafish were sacrificed 1 week after fluoro-emerald tracing and the brains were enzymatically dissociated. Cells were sorted using fluorescence-activated cell sorting. The GSE56842 dataset contains nine samples, including three non-regenerated neuron samples, three regenerated neuron samples, and three non-lesion samples. In the present study, the regenerated neuron samples and non-regenerated neuron samples were selected for analysis.

The original gene expression profile data were analyzed on the Morpheus website (available online: [https://software.broadinstitu te.org/morpheus/](https://software.broadinstitute.org/morpheus/)) to obtain a heat map of the most significant DEGs. GEO2R was used to obtain the DEGs (available online: [https://www.ncb i.nlm.nih.gov/geo/geo2r/](https://www.ncbi.nlm.nih.gov/geo/geo2r/)). We considered *P* \< 0.05 to show statistical significance and \[logFC\] \> 1 as the cut-off value.

Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis {#sec2-2}
--------------------------------------------------------------------------------------

GO analysis is a common method of gene function annotation that can be used for the analysis of transcriptome data (Ashburner et al., 2000, 2006). KEGG is a database resource for studying advanced functions and biological systems from the molecular level, and is especially useful for genomic sequencing data (Ogata et al., 1999). DAVID (available online: <https://david.ncifcrf.gov/>) was used to analyze candidate DEG functions and pathway enrichment. *P* \< 0.05 was considered statistically significant.

Module screening from integration of protein-protein interaction (PPI) networks {#sec2-3}
-------------------------------------------------------------------------------

STRING (available online: <http://string-db.org>) (Franceschini et al., 2013) was employed to evaluate the interaction among DEGs. Cytoscape software (Shannon et al., 2003) was used to analyze the PPI networks. To calculate the number of interconnections, the network analyzer plug-in was used to filter PPI hub genes. The modules of PPI networks were obtained by using Molecular Complex Detection in Cytoscape, and Molecular Complex Detection scores \> 5 were used. Finally, DAVID was used to analyze module pathway enrichment. *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

Identification of DEGs {#sec2-4}
----------------------

Taking *P* \< 0.05 and \[logFC\] \> 1 as inclusion conditions, we identified 636 DEGs, including 255 upregulated and 381 downregulated DEGs, in the regenerated neuron samples compared with the non-regenerated neuron samples from the GSE56842 expression profile dataset. Using the Morpheus website, we obtained a heat map of the top 50 upregulated and downregulated DEGs, revealing the top 100 significantly DEGs (**[Figure 1](#F1){ref-type="fig"}**).

![Heat map of the top 50 up-regulated and down-regulated differentially expressed genes.\
The three columns on the left are the axon-non-regenerated neuron samples. The three columns on the right are the axon-regenerated neuron samples. Blue indicates down-regulation and red indicates up-regulation.](NRR-15-103-g002){#F1}

GO analysis of DEGs {#sec2-5}
-------------------

All DEGs were uploaded to DAVID and the overrepresented GO categories and KEGG pathways were identified. The top 30 enriched GO terms are shown in **[Figure 2](#F2){ref-type="fig"}**; they were mainly in the biological process group, such as multicellular organism development, cell differentiation, and negative regulation of neurogenesis. In the molecular function group, DEGs were mainly enriched in structural constituent of cytoskeleton, cytochrome-c oxidase activity, and protein dimerization activity. There were only two GO terms in the cellular component group, mitochondrial respiratory chain complex IV, and spectrin. The upregulated DEGs were mainly enriched in cytochrome-c oxidase activity, structural constituent of cytoskeleton, mitochondrial respiratory chain complex IV, PDZ domain binding, and spectrin (**[Table 1](#T1){ref-type="table"}**). The downregulated DEGs were mainly enriched in multicellular organism development, negative regulation of neurogenesis, regulation of transcription, positive regulation of sequence-specific DNA binding transcription, and regulation of transcription DNA-templated (**[Table 1](#T1){ref-type="table"}**).

![Top 30 significantly enriched gene ontology (GO) terms of differentially expressed genes in regenerated neurons.\
The green bars represent cellular component. The red bars represent molecular function. The blue bars represent biological process. The length of the bar represents the --log (*P*-value); credibility increases with bar length. The ordinate is the GO terms, and the abscissa is the --log (*P*-value) of GO terms.](NRR-15-103-g003){#F2}

###### 

Top 10 significant enriched gene Gene Ontology (GO) terms of up-regulated and down-regulated differentially expressed genes (DEGs) in regenerated neurons

  Term             Description                                                                          Count   *P*-value
  ---------------- ------------------------------------------------------------------------------------ ------- -----------
  Up-regulated                                                                                                  
  GO: 0004129      Cytochrome-c oxidase activity                                                        6       1.68E-05
  GO: 0005200      Structural constituent of cytoskeleton                                               6       2.98E-04
  GO: 0005751      Mitochondrial respiratory chain complex IV                                           4       5.75E-04
  GO: 0030165      PDZ domain binding                                                                   4       5.89E-04
  GO: 0008091      Spectrin                                                                             3       7.43E-04
  GO: 0006814      Sodium ion transport                                                                 6       1.54E-03
  GO: 0006811      Ion transport                                                                        15      2.44E-03
  GO: 0005890      Sodium:potassium-exchanging ATPase complex                                           3       2.54E-03
  GO: 0005543      Phospholipid binding                                                                 4       5.09E-03
  GO: 0005388      Calcium-transporting ATPase activity                                                 3       9.17E-03
  Down-regulated                                                                                                
  GO: 0007275      Multicellular organism development                                                   31      1.76E-07
  GO: 0050768      Negative regulation of neurogenesis                                                  5       3.42E-05
  GO: 0006355      Regulation of transcription, DNA-templated                                           46      3.60E-05
  GO: 0051091      Positive regulation of sequence-specific DNA binding transcription Factor activity   5       7.20E-05
  GO: 0006351      Transcription, DNA-templated                                                         30      1.34E-04
  GO: 0045666      Positive regulation of neuron differentiation                                        5       2.26E-04
  GO: 0007219      Notch signaling pathway                                                              7       2.73E-04
  GO: 0046983      Protein dimerization activity                                                        12      3.39E-04
  GO: 0030154      Cell differentiation                                                                 14      3.63E-04
  GO: 0042803      Protein homodimerization activity                                                    10      4.14E-04

PDZ: Post-synaptic density protein 95, Drosophila disc large tumor suppressor and zona occludens 1.

Signaling pathway enrichment analysis {#sec2-6}
-------------------------------------

As shown in **[Table 2](#T2){ref-type="table"}**, the upregulated genes were mainly enriched in cardiac muscle contraction, oxidative phosphorylation, adrenergic signaling in cardiomyocytes, Wnt signaling pathway, and oocyte meiosis. The downregulated genes were mainly enriched in biosynthesis of antibiotics, glycine, serine and threonine metabolism, transforming growth factor beta (TGF)-β signaling pathway, and biosynthesis of amino acids. As shown in **[Figure 3](#F3){ref-type="fig"}**, the top 30 enriched pathways were obtained. The most significantly enriched pathways of all DEGs were biosynthesis of antibiotics, cardiac muscle contraction, fatty acid degradation, carbon metabolism, and Wnt signaling pathway.

###### 

Enrichment KEGG pathways of up-regulated and down-regulated DEGs in regenerated neurons

  Pathway                   Name                                       Gene count   *P* value   Genes
  ------------------------- ------------------------------------------ ------------ ----------- -------------------------------------------------------------------------------------------------------------------
  **Up-regulated DEGs**                                                                         
  dre04260                  Cardiac muscle contraction                 9            1.54E-04    *COX6B1*, *ATP1B1B*, *ATP1B2A*, *COX6A1*, *COX5AB*, *ATP1A3B*, *ATP1B2B*, *COX4I1L*, *COX7A2A*
  dre00190                  Oxidative phosphorylation                  10           4.27E-04    *NDUFA4*, *NDUFB5*, *ATPV0E2*, *SDHC*, *COX6B1*, *COX6A1*, *COX5AB*, *COX4I1L*, *COX7A2A*, *ATP6V1F*
  dre04261                  Adrenergic signaling in cardiomyocytes     10           4.66E-03    *CAMK2D1*, *ATP2B2*, *PLCB4*, *CAMK2D2*, *ATP1B1B*, *ATP1B2A*, *ATP1A3B*, *ATP1B2B*, *PPP1CB*, *ATP2B1A*
  dre04310                  Wnt signaling pathway                      8            1.96E-02    *CAMK2D1*, *PRICKLE1A*, *PLCB4*, *CAMK2D2*, *PPP3R1B*, *PPP3CB*, *RHOCB*, *RHOAB*
  dre04114                  Oocyte meiosis                             7            2.27E-02    *CAMK2D1*, *YWHAZ*, *ANAPC13*, *CAMK2D2*, *PPP3R1B*, *PPP3CB*, *PPP1CB*
  dre00071                  Fatty acid degradation                     4            3.27E-02    *GCDHB*, *CPT1AB*, *ACAT1*, *ACSL6*
  dre04145                  Phagosome                                  7            4.08E-02    *MARCO*, *ATPV0E2*, *TUBA2*, *MRC1A*, *TUBB2*, *TUBA8L2*, *ATP6V1F*
  **Down-regulated DEGs**                                                                       
  dre01130                  Biosynthesis of antibiotics                13           1.28E-03    *HADHAA*, *CYP51*, *SHMT2*, *AK3*, *ADH5*, *HADHB*, *FDFT1*, *ENO1B*, *NME5*, *PAPSS2B*, *IDH1*, *PSAT1*, *PAICS*
  dre00260                  Glycine, serine and threonine metabolism   5            9.67E-03    *SHMT2*, *TDH*, *BHMT*, *MAO*, *PSAT1*
  dre04350                  TGF-beta signaling pathway                 7            1.04E-02    *INHBB*, *MYCB*, *BMPR1AA*, *SMURF2*, *DCN*, *BMPR1AB*, *ID2B*
  dre01230                  Biosynthesis of amino acids                6            2.12E-02    *GLULB*, *SHMT2*, *GPT2L*, *IDH1*, *PSAT1*, *ENO1B*
  dre04330                  Notch signaling pathway                    5            2.29E-02    *NOTCH3*, *JAG1B*, *NOTCH1A*, *HER6*, *LFNG*
  dre00062                  Fatty acid elongation                      4            2.72E-02    *HADHAA*, *HACD2*, *ELOVL7A*, *HADHB*
  dre01200                  Carbon metabolism                          7            2.94E-02    *HADHAA*, *SHMT2*, *GPT2L*, *ADH5*, *IDH1*, *PSAT1*, *ENO1B*

DEGs: Differentially expressed genes; KEGG: Kyoto Encyclopedia of Genes and Genomes; TGF: transforming growth factor. The full names of the genes are shown in [Additional Table 1](#T3){ref-type="table"}.

###### 

The full names of the genes in [Table 2](#T2){ref-type="table"}

  Gene symbol       Gene title
  ----------------- --------------------------------------------------------------------------------------------------------------------
  ***ATP1B1B***     Atpase, Na+/K+ transporting, beta 2b polypeptide
  ***ACSL6***       Acyl-coa synthetase long-chain family member 6
  ***ADH5***        Alcohol dehydrogenase 5
  ***AK3***         Adenylate kinase 3
  ***ANAPC13***     Anaphase promoting complex subunit 13
  ***ATP1A3B***     Atpase, Na+/K+ transporting, alpha 3b polypeptide
  ***ATP1B2A***     Atpase, Na+/K+ transporting, beta 2a polypeptide
  ***ATP1B2B***     Atpase, Na+/K+ transporting, beta 2a polypeptide
  ***ATP2B1A***     Atpase, Na+/K+ transporting, beta 2a polypeptide
  ***ATP2B2***      Atpase, Na+/K+ transporting, beta 2a polypeptide
  ***ATP6V1F***     Atpase, Na+/K+ transporting, beta 2a polypeptide
  ***ATPV0E2***     Atpase, Na+/K+ transporting, beta 2a polypeptide
  ***BHMT***        Betaine-homocysteine methyltransferase
  ***BMPR1AA***     Bone morphogenetic protein receptor, type iaa
  ***BMPR1AB***     Bone morphogenetic protein receptor, type iab
  ***CAMK2D1***     Calcium/calmodulin-dependent protein kinase (cam kinase) II delta 1
  ***CAMK2D2***     Calcium/calmodulin-dependent protein kinase (cam kinase) II delta 1
  ***COX4I1L***     Cytochrome c oxidase subunit IV isoform 1, like
  ***COX5AB***      Cytochrome c oxidase subunit Vab
  ***COX6A1***      Cytochrome c oxidase subunit via polypeptide 1
  ***COX6B1***      Cytochrome c oxidase subunit vib polypeptide 1
  ***COX7A2A***     Cytochrome c oxidase subunit viia polypeptide 2a (liver)
  ***CPT1AB***      Carnitine palmitoyltransferase 1Ab (liver)
  ***CYP51***       Cytochrome P450, family 51
  ***DCN***         Decorin
  ***ELOVL7A***     ELOVL fatty acid elongase 7a
  ***ENO1B***       Enolase 1b, (alpha)
  ***FDFT1***       Farnesyl-diphosphate farnesyltransferase 1
  ***GCDHB***       Glutaryl-coa dehydrogenase b
  ***GLULB***       Glutamate-ammonia ligase (glutamine synthase) b
  ***GPT2L***       Glutamic pyruvate transaminase (alanine aminotransferase) 2, like
  ***HACD2***       3-hydroxyacyl-coa dehydratase 2
  ***HADHAA***      Hydroxyacyl-coa dehydrogenase/3-ketoacyl-coa thiolase/enoyl-coa hydratase (trifunctional protein), alpha subunit a
  ***HADHB***       Hydroxyacyl-coa dehydrogenase/3-ketoacyl-coa thiolase/enoyl-coa hydratase (trifunctional protein), beta subunit
  ***HER6***        Hairy-related 6
  ***ID2B***        Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein, b
  ***IDH1***        Isocitrate dehydrogenase 1 (NADP+), soluble
  ***INHBB***       Inhibin, beta B
  ***JAG1B***       Jagged 1b
  ***LFNG***        LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
  ***MAO***         Monoamine oxidase
  ***MARCO***       Macrophage receptor with collagenous structure
  ***MRC1A***       Mannose receptor, C type 1a
  ***MYCB***        V-myc avian myelocytomatosis viral oncogene homolog b
  ***NDUFA4***      NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4
  ***NDUFB5***      NADH dehydrogenase (ubiquinone) 1 beta subcomplex 5
  ***NME5***        NME/NM23 family member 5
  ***NOTCH1A***     Notch 1a
  ***NOTCH3***      Notch 3
  ***PAICS***       Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase
  ***PAPSS2B***     3'-phosphoadenosine 5'-phosphosulfate synthase 2b
  ***PLCB4***       Phospholipase C, beta 4
  ***PPP1CB***      Protein phosphatase 1, catalytic subunit, beta isozyme
  ***PPP3CB***      Protein phosphatase 3, catalytic subunit, beta isozyme
  ***PPP3R1B***     Protein phosphatase 3 (formerly 2B), regulatory s1ubunit B, alpha isoform, b
  ***PRICKLE1A***   Prickle homolog 1a
  ***PSAT1***       Phosphoserine aminotransferase 1
  ***RHOAB***       Ras homolog gene family, member Ab
  ***RHOCB***       Ras homolog gene family, member Ab
  ***SDHC***        Succinate dehydrogenase complex, subunit C, integral membrane protein
  ***SHMT2***       Serine hydroxymethyltransferase 2 (mitochondrial)
  ***SMURF2***      SMAD specific E3 ubiquitin protein ligase 2
  ***TDH***         L-threonine dehydrogenase
  ***TUBA2***       Tubulin, alpha 2
  ***TUBA8L2***     Tubulin, alpha 8 like 2
  ***TUBB2***       Tubulin, beta 2A class iia
  ***YWHAZ***       Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide

![Top 30 significantly enriched pathways of DEGs in regenerated neurons.\
The ordinate is KEGG signaling pathways, and the abscissa is the --log (*P*-value) of pathways. DEGs: Differentially expressed genes; KEGG: Kyoto Encyclopedia of Genes and Genomes.](NRR-15-103-g004){#F3}

PPI network and module analysis {#sec2-7}
-------------------------------

The PPI network contained 480 nodes and 1976 edges. The top 10 hub nodes were obtained and included ras homolog gene family, member Ab (*RHOAB*); catenin (cadherin-associated protein), beta 1 (*CTNNB1*); YES proto-oncogene 1 (*YES1*); phosphoribosylaminoimidazole carboxylase (*PAICS*); mitogen-activated protein kinase 4 (*MAPK4*); Rho family GTPase 3a (*RND3A*); hydroxyacyl-CoA dehydrogenase, alpha subunit a (*HADHAA*); Rho family GTPase 3b (*RND3B*); fibroblast growth factor receptor 2 (*FGFR2*); and v-myc avian myelocytomatosis viral oncogene homolog b (*MYCB*). The top 10 hub genes and their corresponding degrees are shown in **[Table 3](#T4){ref-type="table"}**. Two significant modules with high corresponding degrees were obtained using Molecular Complex Detection in Cytoscape. As shown in **[Figure 4](#F4){ref-type="fig"}**, module 1 consisted of nine nodes and 28 edges, and module 2 consisted of 56 nodes and 173 edges. Through pathway enrichment analysis, we conclude that nodes of module 1 were mainly enriched in focal adhesion, tight junctions, and regulation of actin cytoskeleton (**[Table 4](#T6){ref-type="table"}**), and nodes of module 2 were mainly enriched in cardiac muscle contraction, cytokine-cytokine receptor interaction, and TGF-β signaling pathway (**[Table 5](#T8){ref-type="table"}**).

###### 

Top 10 core genes and their corresponding degree (score), and expression in neurons with axonal regeneration

  Gene       Full name of gene                                Degree   Up or Down
  ---------- ------------------------------------------------ -------- ------------
  *RHOAB*    Ras homolog gene family, member Ab               71       Up
  *CTNNB1*   Catenin (cadherin-associated protein), beta 1    69       Down
  *YES1*     YES proto-oncogene 1                             60       Down
  *PAICS*    Phosphoribosylaminoimidazole carboxylase         54       Down
  *MAPK4*    Mitogen-activated protein kinase 4               49       Down
  *RND3A*    Rho family GTPase 3a                             43       Down
  *HADHAA*   Hydroxyacyl-CoA dehydrogenase, alpha subunit a   42       Down
  *RND3B*    Rho family GTPase 3b                             39       Up
  *FGFR2*    Fibroblast growth factor receptor 2              35       Down
  *MYCB*     Myelocytomatosis viral oncogene homolog b        35       Down

CoA: Coenzyme A; GTP: guanosine triphosphate.

![The top two modules with high corresponding degrees from the protein-protein interaction network.\
(A) The first module and nodes. (B) The second module and nodes. The full names of the proteins are shown in [Additional Table 2](#T5){ref-type="table"}.](NRR-15-103-g005){#F4}

###### 

The full names of the proteins in [Figure 4](#F4){ref-type="fig"}.

  Protein          Protein annotation
  ---------------- ---------------------------------------------------------------------------------------------
  **Abi1a**        Abl-interactor 1a
  **Arf3a**        ADP-ribosylation factor 3a
  **Arvcfb**       Armadillo repeat gene deleted in velocardiofacial syndrome b
  **Atp1a3a**      Atpase, Na+/K+ transporting, alpha 3a polypeptide
  **Atp2b3a**      Atpase, Ca++ transporting, plasma membrane 3a
  **Bcar1**        Breast cancer anti-estrogen resistance 1
  **Bmpr1aa**      Bone morphogenetic protein receptor, type iaa
  **Bmpr1ab**      Bone morphogenetic protein receptor, type iab
  **Calm1a**       Calmodulin 1a
  **Cox5ab**       Cytochrome c oxidase subunit Vab
  **Cox6a1**       Cytochrome c oxidase subunit via polypeptide 1
  **Cox6b1**       Cytochrome c oxidase subunit vib polypeptide 1
  **Cox7a2**       Cytochrome c oxidase subunit viia polypeptide 2a (liver)
  **Crkl**         V-crk avian sarcoma virus CT10 oncogene homolog-like
  **Ctnnb1**       Catenin (cadherin-associated protein), beta 1
  **Ctnnd2a**      Catenin (cadherin-associated protein), delta 2a
  **Ctnnd2b**      Catenin (cadherin-associated protein), delta 2b
  **Cxcl12a**      Chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1)
  **Eef1a1b**      Eukaryotic translation elongation factor 1 alpha 1b
  **ENSDARG00**    Fibroblast growth factor receptor 3
  **000004782**    
  **Fgfr2**        Fibroblast growth factor receptor 2
  **Fgfrl1a**      Fibroblast growth factor receptor-like 1a
  **Fkbp1b**       FK506 binding protein 1b
  **Flt4**         Fms-related tyrosine kinase 4
  **Fzd7a**        Frizzled class receptor 7a
  **Fzd7b**        Frizzled class receptor 7b
  **Gad1b**        Glutamate decarboxylase 1b
  **Gng3**         Guanine nucleotide binding protein (G protein), gamma 3
  **Got1**         Glutamic-oxaloacetic transaminase 1, soluble
  **HSPA4L**       Heat shock protein 4 like
  **Idh1**         Isocitrate dehydrogenase 1 (NADP+), soluble
  **Ilvbl**        Ilvb (bacterial acetolactate synthase)-like
  **Inhbb**        Inhibin, beta B
  **Kita**         V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog a
  **Ldhbb**        Lactate dehydrogenase Bb
  **LOC566572**    Leucine-rich repeat-containing 4
  **Lrrn1**        Leucine rich repeat neuronal 1
  **Mapk4**        Mitogen-activated protein kinase 4
  **Musk**         Muscle, skeletal, receptor tyrosine kinase
  **Mycb**         V-myc avian myelocytomatosis viral oncogene homolog b
  **Myo18aa**      Myosin xviiiaa
  **Ndufa4**       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4
  **Ndufb5**       NADH dehydrogenase (ubiquinone) 1 beta subcomplex 5
  **Nsfa**         N-ethylmaleimide-sensitive factor a
  **OGDHL**        Oxoglutarate dehydrogenase-like
  **Papss2b**      3'-phosphoadenosine 5'-phosphosulfate synthase 2b
  **PKP4**         Plakophilin 4
  **Ptenb**        Phosphatase and tensin homolog B
  **Rasd1**        RAS, dexamethasone-induced 1
  **Rhoab**        Ras homolog gene family, member Ab
  **Rhoad**        Ras homolog gene family, member Ad
  **Rnd3a**        Rho family gtpase 3a
  **S1pr1**        Sphingosine-1-phosphate receptor 1
  **Slc1a2b**      Solute carrier family 1 (glial high affinity glutamate transporter), member 2b
  **Slc32a1**      Solute carrier family 32 (GABA vesicular transporter), member 1
  **Smurf2**       SMAD specific E3 ubiquitin protein ligase 2
  **Snap25b**      Synaptosomal-associated protein, 25b
  **Sypb**         Synaptophysin b
  **Tpm1**         Tropomyosin 1 (alpha)
  **Vav3b**        Vav 3 guanine nucleotide exchange factor b
  **Vegfaa**       Vascular endothelial growth factor Aa
  **Yes1**         YES proto-oncogene 1, Src family tyrosine kinase
  **Ywhaqb**       Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide b
  **Zgc:103663**   Solute carrier family 6 member 1b
  **Zgc:112335**   Tubulin, beta 2A class iia

###### 

The enriched pathways in module 1

  Term                               *P*-value   Count   \%     Genes
  ---------------------------------- ----------- ------- ------ -----------------------------------
  Focal adhesion                     8.77E-04    4       50.0   *CRKL*, *PTENB*, *BCAR1*, *RHOAB*
  Tight junction                     9.89E-03    3       37.5   *PTENB*, *RHOAB*, *YES1*
  Regulation of actin cytoskeleton   2.24E-02    3       37.5   *CRKL*, *BCAR1*, *RHOAB*

The full names of the genes are shown in [Additional Table 3](#T8){ref-type="table"}.

###### 

The full names of the genes in [Table 4](#T4){ref-type="table"}

  Gene symbol   Gene title
  ------------- ------------------------------------------------------
  ***CRKL***    V-crk avian sarcoma virus CT10 oncogene homolog-like
  ***BCAR1***   Breast cancer anti-estrogen resistance 1
  ***PTENB***   Phosphatase and tensin homolog B
  ***RHOAB***   Ras homolog gene family, member Ab
  ***YES1***    YES proto-oncogene 1, Src family tyrosine kinase

###### 

The enriched pathways in module 2

  Term                                     *P*-value   Count   \%      Genes
  ---------------------------------------- ----------- ------- ------- -----------------------------------------------------------
  Cardiac muscle contraction               2.00E-03    5       9.80    *COX6B1*, *COX6A1*, *COX5AB*, *TPM1*, *ATP1A3A*
  Cytokine-cytokine receptor interaction   2.12E-03    6       11.76   *KITA*, *FLT4*, *VEGFAA*, *BMPR1AA*, *BMPR1AB*, *CXCL12A*
  TGF-beta signaling pathway               2.24E-03    5       9.80    *INHBB*, *MYCB*, *BMPR1AA*, *SMURF2*, *BMPR1AB*
  Melanogenesis                            7.17E-03    5       9.80    *KITA*, *FZD7B*, *CALM1A*, *FZD7A*, *CTNNB1*
  Oxidative phosphorylation                7.74E-03    5       9.80    *NDUFA4*, *NDUFB5*, *COX6B1*, *COX6A1*, *COX5AB*
  Biosynthesis of antibiotics              4.18E-02    5       9.80    *GOT1*, *PAPSS2B*, *OGDHL*, *IDH1*, *LDHBB*

TGF: Transforming growth factor. The full names of the genes are shown in [Additional Table 4](#T9){ref-type="table"}.

###### 

The full names of the genes in [Table 5](#T8){ref-type="table"}

  Gene symbol     Gene title
  --------------- --------------------------------------------------------------------
  ***ATP1A3A***   Atpase, Na+/K+ transporting, alpha 3a polypeptide
  ***BMPR1AA***   Bone morphogenetic protein receptor, type iaa
  ***BMPR1AB***   Bone morphogenetic protein receptor, type iab
  ***CALM1A***    Calmodulin 1a
  ***COX5AB***    Cytochrome c oxidase subunit Vab
  ***COX6A1***    Cytochrome c oxidase subunit via polypeptide 1
  ***COX6B1***    Cytochrome c oxidase subunit vib polypeptide 1
  ***CTNNB1***    Catenin (cadherin-associated protein), beta 1
  ***CXCL12A***   Chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1)
  ***FLT4***      Fms-related tyrosine kinase 4
  ***FZD7A***     Frizzled class receptor 7a
  ***FZD7B***     Frizzled class receptor 7b
  ***GOT1***      Glutamic-oxaloacetic transaminase 1, soluble
  ***IDH1***      Isocitrate dehydrogenase 1 (NADP+), soluble
  ***INHBB***     Inhibin, beta B
  ***KITA***      V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog a
  ***LDHBB***     Lactate dehydrogenase Bb
  ***MYCB***      V-myc avian myelocytomatosis viral oncogene homolog b
  ***NDUFA4***    NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4
  ***NDUFB5***    NADH dehydrogenase (ubiquinone) 1 beta subcomplex 5
  ***OGDHL***     Oxoglutarate dehydrogenase-like
  ***PAPSS2B***   3'-phosphoadenosine 5'-phosphosulfate synthase 2b
  ***SMURF2***    SMAD specific E3 ubiquitin protein ligase 2
  ***TPM1***      Tropomyosin 1 (alpha)
  ***VEGFAA***    Vascular endothelial growth factor Aa

Discussion {#sec1-4}
==========

In this study, 636 DEGs were obtained from analysis of cohort profile datasets of GSE56842. GO and KEGG pathway enrichment analyses were then performed. From the GO analysis results, the up-regulated DEGs were involved in cytochrome-c oxidase activity, spectrin, and phospholipid binding, and down-regulated DEGs were involved in negative regulation of neurogenesis, positive regulation of neuron differentiation, Notch signaling and cell differentiation. Spectrins consist of two α and two β subunits and are widely expressed. They have the ability to assemble neuronal excitable regions (Berghs et al., 2000; Yang et al., 2007). Many studies indicate that breakdown of spectrins is an important mechanism in neurodegenerative diseases and injuries. For example, the lack of αII spectrin in mice and zebrafish leads to the death of embryos and larvae because of a stunted nervous system (Stankewich et al., 2011). In fact, spectrins are potent substrates for calpain, and their degradation has been related to brain injury (Schafer et al., 2009). A recent study showed that αII spectrin is critical for the development and synaptogenesis of dendrites and axons (Wang et al., 2018). In the peripheral nervous system of zebrafish, spectrins in Schwann cells can promote the myelination of axons (Susuki et al., 2011). Moreover, Schwann cells are extensively distributed after SCI in zebrafish (Hui et al., 2010). We suggest that spectrins may synergize with Schwann cells to promote nerve regeneration after SCI in zebrafish, and may also promote repair after SCI in mammals.

In most multicellular organisms, the Notch signaling pathway is a highly conserved cellular signaling system that contains four receptors, Notch1--4 (Artavanis-Tsakonas et al., 1999; Kumar et al., 2016). In mammals, Notch1 expression is enhanced in response to injury, and activation of Notch signaling prevents spinal cord progenitor cells from producing neurons. This inhibitory effect can be inhibited *in vitro* by attenuating the Notch signaling pathway (Yamamoto et al., 2001). In addition, Notch signaling inhibits motor neuron generation and progenitor proliferation in the injured ventromedial spinal cord. In zebrafish at 14 days post SCI, Notch1a and Notch1b are significantly upregulated in the spinal cord. Altogether, Notch signaling is a negative signal for nerve regrowth, and inhibiting Notch signaling can enhance the regeneration of spinal motor neurons in adult vertebrates (Dias et al., 2012).

From the KEGG analysis results, the upregulated DEGs were mainly enriched in cardiac muscle contraction, oxidative phosphorylation, adrenergic signaling in cardiomyocytes and Wnt signaling, while downregulated DEGs were mainly enriched in the biosynthesis of antibiotics, glycine, serine and threonine metabolism, TGF-β, biosynthesis of amino acids, Notch signaling pathways and fatty acid elongation. Upregulated DEGs were enriched in cardiac muscle contraction. Adrenergic signaling in cardiomyocytes is mainly because upregulated DEGs contain some genes for cytochrome oxidase, sodium-potassium ATPase and calcium channel. These illustrate that the basal metabolism of neurons is active after axonal regeneration. The Wnt signaling pathway is crucial in development and growth and is associated with cell differentiation, polarization, and migration during development. Wnt signaling is based on one canonical β-catenin-dependent and two β-catenin-independent non-canonical Wnt pathways: the planar cell polarity signaling pathway and the Ca^2+^ Wnt pathway (Taciak et al., 2018). After damage in animals with the ability to regenerate, the activation of Wnt/ß-catenin signaling is enhanced, and attenuating activation of the signaling can inhibit regeneration (Yokoyama et al., 2007). A previous study in zebrafish showed that Wnt/ß-catenin signaling is activated in glia after SCI, and when the signaling pathway is suppressed, neurogenesis is reduced and axon regrowth fails (Briona et al., 2015).

The TGF-β family, which works mainly through the SMAD pathway is composed of evolutionarily conserved polypeptides that have essential functions in homeostasis, growth and development of cells and tissues. However, they also function in the pathogenesis of diseases, including neuronal degeneration and tumor formation (Yamagata et al., 2005; Ueberham et al., 2006; Chalmers and Love, 2007; Jaskova et al., 2014). TGF-β is also an anti-inflammatory cytokine in the injured spinal cord after SCI (Semple-Rowland et al., 1995; Nakamura et al., 2003). A previous study suggested that SCI can lead to elevation of TGF-β, which might lead to the degeneration of neurons and the formation of glial scar after SCI (Joko et al., 2013). Both neuronal degeneration and glial scar are factors that hinder repair after SCI (Yuan and He, 2013; Sofroniew, 2018). Another study showed that inhibition of TGF-β1 in rats can promote axonal regeneration and preservation, and also reduce the formation of glial scar after SCI (Kohta et al., 2009). In mammals, TGF-β hinders nerve regeneration after SCI, and the down-regulated DEGs in the present study are enriched in the TGF-β pathway, indicating that TGF-β may also play a role in inhibiting nerve regeneration in zebrafish SCI.

We identified the top 10 degree hub genes: *RHOAB*, *CTNNB1*, *YES1*, *PAICS*, *MAPK4*, *RND3A*, *HADHAA*, *RND3B*, *FGFR2*, and *MYCB*. Catenin β-1 is encoded by the *CTNNB1* gene. Catenin β-1 participates in the formation of a cadherin protein complex and is also a signal converter of the Wnt signaling pathway, plays an important role in cell adhesion and gene transcription (Peifer et al., 1991, 1994; Noordermeer et al., 1994). In some cell types, an elevated level of β-catenin helps maintain pluripotency, and it may also promote cell differentiation at the developmental stage (Sokol, 2011). Consistent with the GO term results revealing that neuron differentiation and cell differentiation were downregulated, *CTNNB1* was also downregulated in the axon-regenerated neurons. However, previous studies only focused on the promotion of differentiation to facilitate SCI repair (Xu et al., 2017a; Geissler et al., 2018; Li et al., 2018). No studies have described inhibition of the *CTNNB1* gene to promote the repair of SCI.

The proto-oncogene tyrosine-protein kinase, YES, is an enzyme encoded by the *YES1* gene (Semba et al., 1985), which belongs to the Src protein family. Secondary damage after SCI includes edema formation. Vascular endothelial growth factor, an endothelial mitogen as well as a potent mediator of vascular permeability, contributes to brain formation by binding of the vascular endothelial growth factor receptor, leading to recruitment and stimulation of the catalytic activity of Src (Senger et al., 1983; Cobbs et al., 1998; Schlessinger, 2000). An inhibitor of Src family tyrosine kinases reduces edema and the inflammatory response to SCI, subsequently improving motor function (Akiyama et al., 2003, 2004). Fibroblast growth factor receptor 2 (FGFR2), also known as cluster of differentiation 332 (CD332), plays vital roles in embryonic development and tissue repair (Xu et al., 2017b; Ishiwata, 2018). FGFR2 is involved in anti-apoptosis and nerve repair activated by FGF10 (Chen et al., 2017). At present, the role of FGFR2 in the central nervous system is poorly understood. These genes are involved in inflammation, cell proliferation and apoptosis, but their role in SCI is unclear; therefore, the role of these genes is worth studying.

The pathway analysis of modules showed that they were mainly associated with focal adhesion, tight junctions, regulation of actin cytoskeleton, cytokine-cytokine receptor interaction, TGF-β signaling, melanogenesis, and oxidative phosphorylation. In cell biology, focal adhesions are associated with mechanical force and signal transduction between cells or between cells and the extracellular matrix. In addition to anchoring the cell, they act as signal carriers, informing the cell about the condition of the extracellular matrix and thus influence their behavior (Riveline et al., 2001). In addition, focal adhesions are involved in cell motility, proliferation, migration and survival (Zaidel-Bar et al., 2004; Fu et al., 2010; Li et al., 2012; Liu et al., 2018; Yan et al., 2018). Tight junctions, also known as occluding junctions or zonulae occludentes, are multiprotein junctional complexes whose general function is to prevent leakage of transported solutes and water and to seal the paracellular pathway (Anderson and Van Itallie, 2009). Tight junctions also play a critical role in cell migration, proliferation, and differentiation (Kurasawa et al., 2011; Wu et al., 2011; Gonzalez-Mariscal et al., 2017). Although, tight junctions are mainly associated with epithelial and endothelial cells, no study has elucidated the relationship between focal adhesions or tight junctions and SCI. Nevertheless, the migration, proliferation and differentiation of Schwann cells and neural progenitor cells play an important role in repair after SCI in zebrafish (Reimer et al., 2008; Hui et al., 2010; Briona and Dorsky, 2014). However, based on the current findings, we believe that focal adhesion or tight junctions may play an important role in the repair of SCI in zebrafish.

In the present study, through functional enrichment analysis for DEGs, we have highlighted many known pathways involved in the repair of SCI, including Wnt and Notch signaling pathways. By analyzing the top 10 hub genes, we identified several genes worth studying, including *CTNNB1*, *YES1* and *FGFR2*. In addition, through the enrichment of DEGs and functional analysis, we found that spectrins may promote the regeneration of SCI axons in zebrafish and mammals, while TGF-β signals may inhibit repair after SCI in zebrafish. In addition, focal adhesion and tight junctions might promote the migration and proliferation of some zebrafish cells after SCI, such as Schwann cells or neural progenitor cells, and promote repair after SCI.

In summary, this study helps us better understand the repair mechanism of SCI in zebrafish and provides new research targets for mammalian SCI. However, pathway or gene functions were not verified in this study, and more in-depth studies are needed to explore the role of identified genes and pathways in the repair of SCI in zebrafish and mammalian species.

Additional files:
=================

**Additional file 1:** *Open peer review report 1.*

**[Additional Table 1](#T3){ref-type="table"}:** *The full names of the genes in [Table 2](#T2){ref-type="table"}.*

***[Additional Table 2](#T5){ref-type="table"}:*** *The full names of the proteins in [Figure 4](#F4){ref-type="fig"}.*

***[Additional Table 3](#T7){ref-type="table"}:*** *The full names of the genes in [Table 4](#T6){ref-type="table"}.*

***[Additional Table 4](#T9){ref-type="table"}:*** *The full names of the genes in [Table 5](#T8){ref-type="table"}.*

**Conflicts of interest:** *The authors declare that there are no conflicts of interest associated with this manuscript.*

**Financial support:** *This work was supported by the State Key Program of National Natural Science Foundation of China, No. 81330042 (to SQF); the International Cooperation Program of the National Natural Science Foundation of China, No. 81620108018 (to SQF). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.*

**Copyright license agreement:** *The Copyright License Agreement has been signed by all authors before publication.*

**Data sharing statement:** *Datasets analyzed during the current study are available from the corresponding author on reasonable request.*

**Plagiarism check:** *Checked twice by iThenticate.*

**Peer review:** *Externally peer reviewed.*

**Open peer reviewer:** *He Huang, Central South University Xiangya School of Medicine, China.*

***Funding*:** *This work was supported by the State Key Program of National Natural Science Foundation of China, No. 81330042 (to SQF); the International Cooperation Program of the National Natural Science Foundation of China, No. 81620108018 (to SQF).*

P-Reviewer: Huang H; C-Editor: Zhao M; S-Editors: Wang J, Li CH; L-Editors: Allen J, Hindle A, Qiu Y, Song LP; T-Editor: Jia Y

[^1]: **Author contributions:** *Study design: JHL, ZJS, YL; data analysis: JHL, BP; paper writing: JHL; critical revision of the manuscript for intellectual content: SYY, LLS, YH, FJC, SQF; fundraising: SQF. All authors approved the final version of the paper.*

[^2]: *These authors contributed equally to this work*.
